Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau.
TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs.
By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases.
Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 28, Rue Du Docteur Roux, Paris,île-De-France 75015,france
- Phone
- 33 1 44 38 93 13
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.theravectys.com
- Keywords
- Biotechnology, Oncology, Therapeutic vaccines, Infectious Diseases, Prophylactic vaccines, Immunotherapy, Tropical Diseases, Lentiviral vectors.
- HQ
- Paris, Île-de-France
Theravectys Questions
Theravectys's helpline number is 33 1 44 38 93 13
Theravectys's website is http://www.theravectys.com
Theravectys's LinkedIn profile is https://www.linkedin.com/company/theravectys
Theravectys has
19 employees.
View email and phone details for 19
employees at Theravectys.
Theravectys's industry is
Biotechnology Research
Theravectys's top competitors are
Cellectis,
Innate Pharma,
Smart Immune,
Enterome,
Eligo Bioscience,
Invectys,
Mnemo Therapeutics,
Oncovita,
Abivax,
Stimunity.
Theravectys's categories are Biotechnology Research
Theravectys's founding year is 2005
